KRAS mediates signal transduction between membrane growth factor receptors and downstream pathways, such as PI3K/AKT/mTOR and RAS/RAF/MEK/ERK, which all contribute to tumor growth, progression, and metastasis [30]. The gene discussed is KRAS; the disease is neoplasm.